1 – 3 of 3
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Tauopathy models in Neuro2a and C6 cell-lines, regarding Alzheimer's disease
(
- Master (Two yrs)
- 2021
-
Mark
Activating TFEB and ADAM17 using CRISPRa to treat neurodegenerative diseases
(
- Master (Two yrs)
- 2013
-
Mark
The development of an alpha synuclein overexpressing In vitro model for parkinson's disease research
(
- Master (Two yrs)